A new technology entitled GeneXpert was deemed a ‘game-changer’ in the world of TB diagnostics. To reduce the burden and mortality of TB, it is imperative to not only have advanced technologies to detect TB bacteria, but to also have experts that know how to use the new technology. In 2016, USAID TB CARE II funded the attendance of 11 people from select low or middle‐income countries to attend the McGill Summer Institute in Infectious Diseases and Global Health to take courses on Advanced TB Diagnostic Research. The objectives of the courses were for participants to advance their learning on TB diagnostics, and be inspired to adopt and implement innovative tools and approaches and become champions for TB control. Click here to download the fact sheet.